Navigation Links
By Targeting Specific Germs, Hospital Hopes to Improve Pneumonia Treatment

By analyzing patient characteristics and the particular bacteria causing some patients to develop pneumonia during hospital stays// , Wake Forest University Baptist Medical Center has developed treatment guidelines to more effectively target the germs.

“We matched the best antibiotic combination to each patient’s characteristics and the particular bugs that we have in our hospital,” said James Beardsley, Pharm.D., lead author of the article in this month’s issue of the journal Chest. “We learned that some of the commonly recommended drugs wouldn’t have worked for many of our patients.”

The researchers estimate that antibiotic therapy under the new hospital-specific guidelines will target the correct bacteria in at least 90 percent of cases at risk of being resistant to treatment. If national guidelines were followed, treatment may have correctly targeted the germs in only 70 percent of cases.

Pneumonia is one of the most common hospital-acquired infections. The American Thoracic Society and the Infectious Diseases Society of America joined together to publish national guidelines for treating pneumonia that develops in health care settings, often as a result of patients being on respirators.

Once a patient develops pneumonia, it takes two or three days for laboratory tests to determine exactly what bacteria caused the illness. But treatment must begin right away, so physicians generally use an antibiotic known to be effective against the bacteria that most commonly cause pneumonia. Some patients, especially those who have been in the hospital for several days, are at risk of being infected with bacteria that are resistant to these drugs. This can make it challenging to select the correct antibiotics.

“The choice of which antibiotics to start is very important,” said Beardsley. “They need to cover the germs that are causing the pneumonia in that particular patient. If you’re not right from the start, people ar e at higher risk of dying.”

To improve the effectiveness of therapy, national guidelines recommend that hospitals base drug selection on the characteristics of the bacteria in their institutions. However, specific recommendations on how to accomplish this are not widely agreed on. Wake Forest Baptist’s report is believed to the first published description of a process using hospital data on infection-causing bacteria to develop institution-specific guidelines for treatment of pneumonia.

The Medical Center project was part of an overall effort to improve care of pneumonia acquired in the hospital. Team members reviewed six months of pneumonia cases from 2004 – a total of 115 cases – to learn which bacteria had caused the pneumonia. They found that at Baptist Hospital, it was patients who had been hospitalized at least 10 days who were most at risk of being infected with bacteria resistant to the most common antibiotics.

The group analyzed each episode of late-onset pneumonia to determine the adequacy of various drug combinations. The goal was to determine which drugs should be used and under what circumstances. They are currently looking at 2006 pathogens to see if the bacteria have changed – which could require an update of the internal guidelines.

In addition to making sure that patients get the most effective therapy, the project also helps the hospital be better stewards of antibiotics, Beardsley said.

“Improper use of antibiotics – whether it is under-dosing, over-use, or prescribing a drug that isn’t effective against the pathogen – hurts our ability to treat the next infected person because resistance can develop,” he said.

Sorce-Newswise
SRM
'"/>




Related medicine news :

1. Novel Technique For Targeting Small-Cell Lung Cancer
2. Targeting PARP1 Is Effective In Protecting HD Cells from Damage
3. Ad Campaign Targeting Republicans On Medicare Prescription Drug Program
4. Highly Potent TB Strain Plays Favorites Targeting Specific Ethnic Groups
5. New Asthma Medicine Targeting Vulnerable Inner-City Children Tested
6. Targeting a Single Gene Could Inhibit Bone Decay and Stimulate Bone Growth
7. Researchers Find Stem-cell Therapy Effective in Targeting Metastatic Cancer
8. Targeting the Adrenal Gland Could Be Key Against Heart Failure
9. Targeting SOCS-3 can Control Obesity
10. Sex Abstinence Programs Targeting School-goers may Not Produce Desired Effect , Study
11. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/25/2017)... ... April 25, 2017 , ... Saad B. Chaudhary, MD is committed to providing the highest quality ... problems, I focus on preventative care with all my patients to alleviate possible future issues. ... feel free to contact my office and my trained staff will assist you in any ...
(Date:4/25/2017)... ... ... Emergency Physician and Distinguished Professor of Emergency Medicine Bentley Bobrow will be featured ... publish in summer 2017. , Dr. Bobrow, MD, FACEP, FAHA, is an Emergency ... He also serves as Medical Director for the Bureau of Emergency Medical Services and ...
(Date:4/25/2017)... ... April 25, 2017 , ... ... products, is introducing Flexadin UCII, part of the EQUISTRO line, at this week’s ... health in horses at the immunologic level. , The scientifically-developed Flexadin UCII supports ...
(Date:4/24/2017)... ... ... Emmanuel College is introducing enhancements to its RN-to-BSN Degree ... fall of 2017, Emmanuel’s program will allow registered nurses (RN)s to earn a Bachelor ... as little as $14,528. These changes will enable nurses to complete their degree in ...
(Date:4/24/2017)... ... , ... Michael Vick announced his retirement earlier this year from the NFL ... one pick in the 2001 NFL Draft, to the Atlanta Falcons, made four Pro ... career rushing yards by a quarterback (6,109) and the most rushing yards by a ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... -- New research provides evidence that an old drug may provide ... released today that will be presented at the American ... Boston , April 22 to 28, 2017. ... the oral drug levodopa has long been considered the gold ... disease progresses, the effects of the medication can partially wear ...
(Date:4/19/2017)... April 19, 2017  SARES•REGIS Group leased the ... developing at Conejo Spectrum Business Park in ... Atara Biotherapeutics, Inc. , a biopharmaceutical company developing ... diseases that have been underserved by scientific innovation, ... for cancer, autoimmune and infectious disease. ...
(Date:4/18/2017)... -- Cogentix Medical, Inc. (NASDAQ: CGNT), a global medical ... Gynecology markets with innovative and proprietary products, will release ... 2017 after the market close on Tuesday, May 2, ... conference call and webcast to discuss its financial results ... 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ...
Breaking Medicine Technology: